Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.
Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Chief Strategy Officer | Willwerth Christina | Jul 19, 2021 | Sell | $25.45K | 3,945 |
| Chief Regulatory Officer | Wentworth Kerry | Jul 19, 2021 | Sell | $25.44K | 3,944 |
| General Counsel | Levine Mark S. | Jul 19, 2021 | Sell | $25.45K | 3,945 |
| Chief Business Officer | Muzikant Adam | Jul 19, 2021 | Sell | $12.06K | 1,870 |
| CFO | Arkowitz David | May 10, 2021 | Sell | $16.12K | 2,229 |
| Chief Commercial Officer | Layman Melissa | Mar 15, 2021 | Sell | $53.34K | 4,520 |
| Chief Commercial Officer | Layman Melissa | Jan 28, 2021 | Sell | $32.93K | 2,624 |
| Chief Medical Officer | KELLEY SCOTT | Jan 5, 2021 | Sell | $76.01K | 6,829 |
| Chief Strategy Officer | Willwerth Christina | Jan 5, 2021 | Sell | $73.48K | 6,602 |
| CFO | Arkowitz David | Jan 5, 2021 | Sell | $67.59K | 6,073 |
| Chief Regulatory Officer | Wentworth Kerry | Jan 5, 2021 | Sell | $76.01K | 6,829 |
| General Counsel | Levine Mark S. | Jan 5, 2021 | Sell | $76.01K | 6,829 |
| Chief Business Officer | Muzikant Adam | Jan 5, 2021 | Sell | $44.58K | 4,005 |
| CEO | Clayman Michael D. | May 26, 2020 | Buy | $100K | 10,256 |
| Director | Stejbach Mark | May 26, 2020 | Buy | $20K | 2,051 |
| CFO | Arkowitz David | May 7, 2020 | Sell | $26.25K | 2,413 |
| Chief Scientific Officer | Bodick Neil | Jan 3, 2020 | Sell | - | 3,851 |
| CFO | Arkowitz David | Jan 3, 2020 | Sell | - | 3,095 |
| Chief Regulatory Officer | Wentworth Kerry | Jan 3, 2020 | Sell | - | 3,724 |
| Chief Medical Officer | KELLEY SCOTT | Jan 3, 2020 | Sell | - | 3,724 |
| General Counsel | Levine Mark S. | Jan 3, 2020 | Sell | - | 3,724 |
| Chief Strategy Officer | Willwerth Christina | Jan 3, 2020 | Sell | - | 3,533 |
| Director | COLELLA SAMUEL D | Aug 8, 2019 | Buy | $21.48K | 2,000 |
| CEO | Clayman Michael D. | Aug 8, 2019 | Buy | $25.14K | 2,317 |
| CFO | Arkowitz David | May 31, 2019 | Buy | $27.63K | 2,500 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.